DYNAMICS OF  POST-STRESS SYMPTOMS IN  PATIENTS WITH STRESS-ASSOCIATED DISORDERS DURING STANDARD INPATIENT TREATMENT

The aim of the study was to study the dynamics of post-stress symptoms (PSS) in patients with stress-related disorders during standard inpatient treatment. Twice (at the beginning and end of inpatient treatment) using the Connor-Davidson Resilience Scale (CD-RISC-25) and the Mississippi Scale for Combat-Related Posttraumatic Stress (M-PTSD), 115 people with complaints of various consequences of traumatic events related to participation in combat or being in a combat zone (including military personnel — 58 people (all men)), with the following diagnoses at the time of hospitalization: adjustment disorders (F43.2) — 44 people; post-traumatic stress disorder (F43.1) — 36 people; anxiety-phobic disorders (F40.0) — 20 people and anxiety disorders (F41) — 15 people. The obtained data were processed by mathematical statistical methods (variance and correlation analyses) on a computer using Excel 2016 spread-sheets (with the Data Analysis package). It was found that on average during standard inpatient therapy, stress resistance (on the CD-RISC-25 scale) increases by 6.77 ± 2.98 % (at p = 0.0068004) compared to the base-line, and the severity of post-stress symptoms (on the M-PTSD scale) decreases by 11.06 ± 1.64 % (at p = 0.0000001), with the greatest reduction in these symptoms observed in the cluster of intrusion symptoms (13.80 ± 2.06 %), and the smallest in the cluster of guilt and suicidality symptoms (5.38 ± 2.35 %). It is shown that the specialized medical care provided by the current Protocol can provide a positive response to therapy in less than half (45.87 %) of patients hospitalized for stress-associated disorders (when using the degree of reduction of PSS on the M-PTSD scale by more than 10 % from the baseline as a criterion for the effectiveness of therapy). The conclusion is made about the need to develop and implement innovative treatment methods capable of increasing the effectiveness of the treatment of stress-associated disorders.